PTPN6 and neoplasm: Certainly, other parameters will have to be further evaluated for determinate why SHP-1 and SSTR2 expression diminish, establishing as a possible tumor suppressor gene role of this proteins in human prostate and determining the therapeutic potential of SHP-1 in clinical outcome, that is, survival and tumor recurrence.